Steven Romick - First Pacific Advisors
Holding/activity history for Edwards Lifesciences Corp. (EW)
← All EW superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $85.58–131.10 · VW $102.98i | SEC | |
| 2022 Q1 | 1,818 | <0.01 | $117.71 | $214,000 | SEC | ||
| 2021 Q4 | 1,818 | <0.01 | $129.81 | $236,000 | SEC | ||
| 2021 Q3 | 1,818 | <0.01 | $113.31 | $206,000 | SEC | ||
| 2021 Q2 | 1,818 | <0.01 | $103.41 | $188,000 | SEC | ||
| 2021 Q1 | 1,818 | <0.01 | $83.61 | $152,000 | SEC | ||
| 2020 Q4 | 1,818 | <0.01 | Reduce 3.04% | <0.01 | $70.92–92.08 · VW $82.08i | $166,000 | SEC |
| 2020 Q3 | 1,875 | <0.01 | $80.00 | $150,000 | SEC | ||
| 2020 Q2 | 1,875 | <0.01 | $69.33 | $130,000 | SEC | ||
| 2020 Q1 | 1,875 | <0.01 | Buy | <0.01 | $51.51–81.90 · VW $68.42i | $118,000 | SEC |
Price snapshot:
Current price$91.79
52-week low$72.30
52-week high$96.29